The global market for Infectious Disease POC Diagnostic was valued at US$ 1652 million in the year 2024 and is projected to reach a revised size of US$ 3251 million by 2031, growing at a CAGR of 10.3% during the forecast period.

Infectious Disease POC Diagnostic Market

Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results、 Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Disease POC Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease POC Diagnostic.

The Infectious Disease POC Diagnostic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease POC Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Disease POC Diagnostic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Infectious Disease POC Diagnostic Market Report

Report Metric	Details
Report Name	Infectious Disease POC Diagnostic Market
Accounted market size in year	US$ 1652 million
Forecasted market size in 2031	US$ 3251 million
CAGR	10.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lateral Flow Immunoassay Agglutination Test Flow-Through Test Molecular Diagnostics Others
Segment by Application	Hospital Bedside Urgent Care and Retail Clinics Home and Self-Testing Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	F. Hoffmann-La Roche, Thermo Fisher Scientific, Abbott Laboratories, Quest Diagnostics, BD, bioMérieux, Cardinal Health, Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infectious Disease POC Diagnostic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infectious Disease POC Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease POC Diagnostic Market growing?

Ans: The Infectious Disease POC Diagnostic Market witnessing a CAGR of 10.3% during the forecast period 2025-2031.

What is the Infectious Disease POC Diagnostic Market size in 2031?

Ans: The Infectious Disease POC Diagnostic Market size in 2031 will be US$ 3251 million.

Who are the main players in the Infectious Disease POC Diagnostic Market report?

Ans: The main players in the Infectious Disease POC Diagnostic Market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Abbott Laboratories, Quest Diagnostics, BD, bioMérieux, Cardinal Health, Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories

What are the Application segmentation covered in the Infectious Disease POC Diagnostic Market report?

Ans: The Applications covered in the Infectious Disease POC Diagnostic Market report are Hospital Bedside, Urgent Care and Retail Clinics, Home and Self-Testing, Others

What are the Type segmentation covered in the Infectious Disease POC Diagnostic Market report?

Ans: The Types covered in the Infectious Disease POC Diagnostic Market report are Lateral Flow Immunoassay, Agglutination Test, Flow-Through Test, Molecular Diagnostics, Others

1 Infectious Disease POC Diagnostic Market Overview

1.1 Product Definition

1.2 Infectious Disease POC Diagnostic by Type

1.2.1 Global Infectious Disease POC Diagnostic Market Value Comparison by Type (2024 VS 2031)

1.2.2 Lateral Flow Immunoassay

1.2.3 Agglutination Test

1.2.4 Flow-Through Test

1.2.5 Molecular Diagnostics

1.2.6 Others

1.3 Infectious Disease POC Diagnostic by Application

1.3.1 Global Infectious Disease POC Diagnostic Market Value by Application (2024 VS 2031)

1.3.2 Hospital Bedside

1.3.3 Urgent Care and Retail Clinics

1.3.4 Home and Self-Testing

1.3.5 Others

1.4 Global Infectious Disease POC Diagnostic Market Size Estimates and Forecasts

1.4.1 Global Infectious Disease POC Diagnostic Revenue 2020-2031

1.4.2 Global Infectious Disease POC Diagnostic Sales 2020-2031

1.4.3 Global Infectious Disease POC Diagnostic Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Infectious Disease POC Diagnostic Market Competition by Manufacturers

2.1 Global Infectious Disease POC Diagnostic Sales Market Share by Manufacturers (2020-2025)

2.2 Global Infectious Disease POC Diagnostic Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Infectious Disease POC Diagnostic Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Infectious Disease POC Diagnostic, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Infectious Disease POC Diagnostic, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Infectious Disease POC Diagnostic, Product Type & Application

2.7 Global Key Manufacturers of Infectious Disease POC Diagnostic, Date of Enter into This Industry

2.8 Global Infectious Disease POC Diagnostic Market Competitive Situation and Trends

2.8.1 Global Infectious Disease POC Diagnostic Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Infectious Disease POC Diagnostic Players Market Share by Revenue

2.8.3 Global Infectious Disease POC Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Infectious Disease POC Diagnostic Market Scenario by Region

3.1 Global Infectious Disease POC Diagnostic Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Infectious Disease POC Diagnostic Sales by Region: 2020-2031

3.2.1 Global Infectious Disease POC Diagnostic Sales by Region: 2020-2025

3.2.2 Global Infectious Disease POC Diagnostic Sales by Region: 2026-2031

3.3 Global Infectious Disease POC Diagnostic Revenue by Region: 2020-2031

3.3.1 Global Infectious Disease POC Diagnostic Revenue by Region: 2020-2025

3.3.2 Global Infectious Disease POC Diagnostic Revenue by Region: 2026-2031

3.4 North America Infectious Disease POC Diagnostic Market Facts & Figures by Country

3.4.1 North America Infectious Disease POC Diagnostic Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Infectious Disease POC Diagnostic Sales by Country (2020-2031)

3.4.3 North America Infectious Disease POC Diagnostic Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Infectious Disease POC Diagnostic Market Facts & Figures by Country

3.5.1 Europe Infectious Disease POC Diagnostic Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Infectious Disease POC Diagnostic Sales by Country (2020-2031)

3.5.3 Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Infectious Disease POC Diagnostic Market Facts & Figures by Region

3.6.1 Asia Pacific Infectious Disease POC Diagnostic Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2020-2031)

3.6.3 Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Infectious Disease POC Diagnostic Market Facts & Figures by Country

3.7.1 Latin America Infectious Disease POC Diagnostic Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Infectious Disease POC Diagnostic Sales by Country (2020-2031)

3.7.3 Latin America Infectious Disease POC Diagnostic Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Infectious Disease POC Diagnostic Market Facts & Figures by Country

3.8.1 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2020-2031)

3.8.3 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Infectious Disease POC Diagnostic Sales by Type (2020-2031)

4.1.1 Global Infectious Disease POC Diagnostic Sales by Type (2020-2025)

4.1.2 Global Infectious Disease POC Diagnostic Sales by Type (2026-2031)

4.1.3 Global Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2031)

4.2 Global Infectious Disease POC Diagnostic Revenue by Type (2020-2031)

4.2.1 Global Infectious Disease POC Diagnostic Revenue by Type (2020-2025)

4.2.2 Global Infectious Disease POC Diagnostic Revenue by Type (2026-2031)

4.2.3 Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2020-2031)

4.3 Global Infectious Disease POC Diagnostic Price by Type (2020-2031)

5 Segment by Application

5.1 Global Infectious Disease POC Diagnostic Sales by Application (2020-2031)

5.1.1 Global Infectious Disease POC Diagnostic Sales by Application (2020-2025)

5.1.2 Global Infectious Disease POC Diagnostic Sales by Application (2026-2031)

5.1.3 Global Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2031)

5.2 Global Infectious Disease POC Diagnostic Revenue by Application (2020-2031)

5.2.1 Global Infectious Disease POC Diagnostic Revenue by Application (2020-2025)

5.2.2 Global Infectious Disease POC Diagnostic Revenue by Application (2026-2031)

5.2.3 Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2020-2031)

5.3 Global Infectious Disease POC Diagnostic Price by Application (2020-2031)

6 Key Companies Profiled

6.1 F. Hoffmann-La Roche

6.1.1 F. Hoffmann-La Roche Company Information

6.1.2 F. Hoffmann-La Roche Description and Business Overview

6.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.1.4 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Portfolio

6.1.5 F. Hoffmann-La Roche Recent Developments/Updates

6.2 Thermo Fisher Scientific

6.2.1 Thermo Fisher Scientific Company Information

6.2.2 Thermo Fisher Scientific Description and Business Overview

6.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Portfolio

6.2.5 Thermo Fisher Scientific Recent Developments/Updates

6.3 Abbott Laboratories

6.3.1 Abbott Laboratories Company Information

6.3.2 Abbott Laboratories Description and Business Overview

6.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Laboratories Infectious Disease POC Diagnostic Product Portfolio

6.3.5 Abbott Laboratories Recent Developments/Updates

6.4 Quest Diagnostics

6.4.1 Quest Diagnostics Company Information

6.4.2 Quest Diagnostics Description and Business Overview

6.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Quest Diagnostics Infectious Disease POC Diagnostic Product Portfolio

6.4.5 Quest Diagnostics Recent Developments/Updates

6.5 BD

6.5.1 BD Company Information

6.5.2 BD Description and Business Overview

6.5.3 BD Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.5.4 BD Infectious Disease POC Diagnostic Product Portfolio

6.5.5 BD Recent Developments/Updates

6.6 bioMérieux

6.6.1 bioMérieux Company Information

6.6.2 bioMérieux Description and Business Overview

6.6.3 bioMérieux Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.6.4 bioMérieux Infectious Disease POC Diagnostic Product Portfolio

6.6.5 bioMérieux Recent Developments/Updates

6.7 Cardinal Health

6.7.1 Cardinal Health Company Information

6.7.2 Cardinal Health Description and Business Overview

6.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Cardinal Health Infectious Disease POC Diagnostic Product Portfolio

6.7.5 Cardinal Health Recent Developments/Updates

6.8 Cepheid

6.8.1 Cepheid Company Information

6.8.2 Cepheid Description and Business Overview

6.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Cepheid Infectious Disease POC Diagnostic Product Portfolio

6.8.5 Cepheid Recent Developments/Updates

6.9 Trinity Biotech

6.9.1 Trinity Biotech Company Information

6.9.2 Trinity Biotech Description and Business Overview

6.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Trinity Biotech Infectious Disease POC Diagnostic Product Portfolio

6.9.5 Trinity Biotech Recent Developments/Updates

6.10 Quidel Corporation

6.10.1 Quidel Corporation Company Information

6.10.2 Quidel Corporation Description and Business Overview

6.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Quidel Corporation Infectious Disease POC Diagnostic Product Portfolio

6.10.5 Quidel Corporation Recent Developments/Updates

6.11 Bio-Rad Laboratories

6.11.1 Bio-Rad Laboratories Company Information

6.11.2 Bio-Rad Laboratories Description and Business Overview

6.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Portfolio

6.11.5 Bio-Rad Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Infectious Disease POC Diagnostic Industry Chain Analysis

7.2 Infectious Disease POC Diagnostic Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Infectious Disease POC Diagnostic Production Mode & Process Analysis

7.4 Infectious Disease POC Diagnostic Sales and Marketing

7.4.1 Infectious Disease POC Diagnostic Sales Channels

7.4.2 Infectious Disease POC Diagnostic Distributors

7.5 Infectious Disease POC Diagnostic Customer Analysis

8 Infectious Disease POC Diagnostic Market Dynamics

8.1 Infectious Disease POC Diagnostic Industry Trends

8.2 Infectious Disease POC Diagnostic Market Drivers

8.3 Infectious Disease POC Diagnostic Market Challenges

8.4 Infectious Disease POC Diagnostic Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

F.Hoffmann-La Roche

Thermo Fisher Scientific

List of Tables

Table 1. Global Infectious Disease POC Diagnostic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Infectious Disease POC Diagnostic Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Infectious Disease POC Diagnostic Market Competitive Situation by Manufacturers in 2024

Table 4. Global Infectious Disease POC Diagnostic Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Infectious Disease POC Diagnostic Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Infectious Disease POC Diagnostic Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Infectious Disease POC Diagnostic Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Infectious Disease POC Diagnostic Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Infectious Disease POC Diagnostic, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Infectious Disease POC Diagnostic, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Infectious Disease POC Diagnostic, Product Type & Application

Table 12. Global Key Manufacturers of Infectious Disease POC Diagnostic, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Infectious Disease POC Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease POC Diagnostic as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Infectious Disease POC Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Infectious Disease POC Diagnostic Sales by Region (2020-2025) & (K Units)

Table 18. Global Infectious Disease POC Diagnostic Sales Market Share by Region (2020-2025)

Table 19. Global Infectious Disease POC Diagnostic Sales by Region (2026-2031) & (K Units)

Table 20. Global Infectious Disease POC Diagnostic Sales Market Share by Region (2026-2031)

Table 21. Global Infectious Disease POC Diagnostic Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Infectious Disease POC Diagnostic Revenue Market Share by Region (2020-2025)

Table 23. Global Infectious Disease POC Diagnostic Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Infectious Disease POC Diagnostic Revenue Market Share by Region (2026-2031)

Table 25. North America Infectious Disease POC Diagnostic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)

Table 27. North America Infectious Disease POC Diagnostic Sales by Country (2026-2031) & (K Units)

Table 28. North America Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Infectious Disease POC Diagnostic Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Infectious Disease POC Diagnostic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)

Table 32. Europe Infectious Disease POC Diagnostic Sales by Country (2026-2031) & (K Units)

Table 33. Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Infectious Disease POC Diagnostic Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Infectious Disease POC Diagnostic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Infectious Disease POC Diagnostic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Infectious Disease POC Diagnostic Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Infectious Disease POC Diagnostic Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Infectious Disease POC Diagnostic Sales (K Units) by Type (2020-2025)

Table 51. Global Infectious Disease POC Diagnostic Sales (K Units) by Type (2026-2031)

Table 52. Global Infectious Disease POC Diagnostic Sales Market Share by Type (2020-2025)

Table 53. Global Infectious Disease POC Diagnostic Sales Market Share by Type (2026-2031)

Table 54. Global Infectious Disease POC Diagnostic Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Infectious Disease POC Diagnostic Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2020-2025)

Table 57. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2026-2031)

Table 58. Global Infectious Disease POC Diagnostic Price (US$/Unit) by Type (2020-2025)

Table 59. Global Infectious Disease POC Diagnostic Price (US$/Unit) by Type (2026-2031)

Table 60. Global Infectious Disease POC Diagnostic Sales (K Units) by Application (2020-2025)

Table 61. Global Infectious Disease POC Diagnostic Sales (K Units) by Application (2026-2031)

Table 62. Global Infectious Disease POC Diagnostic Sales Market Share by Application (2020-2025)

Table 63. Global Infectious Disease POC Diagnostic Sales Market Share by Application (2026-2031)

Table 64. Global Infectious Disease POC Diagnostic Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Infectious Disease POC Diagnostic Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2020-2025)

Table 67. Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2026-2031)

Table 68. Global Infectious Disease POC Diagnostic Price (US$/Unit) by Application (2020-2025)

Table 69. Global Infectious Disease POC Diagnostic Price (US$/Unit) by Application (2026-2031)

Table 70. F. Hoffmann-La Roche Company Information

Table 71. F. Hoffmann-La Roche Description and Business Overview

Table 72. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product

Table 74. F. Hoffmann-La Roche Recent Developments/Updates

Table 75. Thermo Fisher Scientific Company Information

Table 76. Thermo Fisher Scientific Description and Business Overview

Table 77. Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Thermo Fisher Scientific Infectious Disease POC Diagnostic Product

Table 79. Thermo Fisher Scientific Recent Developments/Updates

Table 80. Abbott Laboratories Company Information

Table 81. Abbott Laboratories Description and Business Overview

Table 82. Abbott Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Abbott Laboratories Infectious Disease POC Diagnostic Product

Table 84. Abbott Laboratories Recent Developments/Updates

Table 85. Quest Diagnostics Company Information

Table 86. Quest Diagnostics Description and Business Overview

Table 87. Quest Diagnostics Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Quest Diagnostics Infectious Disease POC Diagnostic Product

Table 89. Quest Diagnostics Recent Developments/Updates

Table 90. BD Company Information

Table 91. BD Description and Business Overview

Table 92. BD Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. BD Infectious Disease POC Diagnostic Product

Table 94. BD Recent Developments/Updates

Table 95. bioMérieux Company Information

Table 96. bioMérieux Description and Business Overview

Table 97. bioMérieux Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. bioMérieux Infectious Disease POC Diagnostic Product

Table 99. bioMérieux Recent Developments/Updates

Table 100. Cardinal Health Company Information

Table 101. Cardinal Health Description and Business Overview

Table 102. Cardinal Health Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Cardinal Health Infectious Disease POC Diagnostic Product

Table 104. Cardinal Health Recent Developments/Updates

Table 105. Cepheid Company Information

Table 106. Cepheid Description and Business Overview

Table 107. Cepheid Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Cepheid Infectious Disease POC Diagnostic Product

Table 109. Cepheid Recent Developments/Updates

Table 110. Trinity Biotech Company Information

Table 111. Trinity Biotech Description and Business Overview

Table 112. Trinity Biotech Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Trinity Biotech Infectious Disease POC Diagnostic Product

Table 114. Trinity Biotech Recent Developments/Updates

Table 115. Quidel Corporation Company Information

Table 116. Quidel Corporation Description and Business Overview

Table 117. Quidel Corporation Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Quidel Corporation Infectious Disease POC Diagnostic Product

Table 119. Quidel Corporation Recent Developments/Updates

Table 120. Bio-Rad Laboratories Company Information

Table 121. Bio-Rad Laboratories Description and Business Overview

Table 122. Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Bio-Rad Laboratories Infectious Disease POC Diagnostic Product

Table 124. Bio-Rad Laboratories Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Infectious Disease POC Diagnostic Distributors List

Table 128. Infectious Disease POC Diagnostic Customers List

Table 129. Infectious Disease POC Diagnostic Market Trends

Table 130. Infectious Disease POC Diagnostic Market Drivers

Table 131. Infectious Disease POC Diagnostic Market Challenges

Table 132. Infectious Disease POC Diagnostic Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Infectious Disease POC Diagnostic

Figure 2. Global Infectious Disease POC Diagnostic Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Infectious Disease POC Diagnostic Market Share by Type: 2024 & 2031

Figure 4. Lateral Flow Immunoassay Product Picture

Figure 5. Agglutination Test Product Picture

Figure 6. Flow-Through Test Product Picture

Figure 7. Molecular Diagnostics Product Picture

Figure 8. Others Product Picture

Figure 9. Global Infectious Disease POC Diagnostic Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Infectious Disease POC Diagnostic Market Share by Application: 2024 & 2031

Figure 11. Hospital Bedside

Figure 12. Urgent Care and Retail Clinics

Figure 13. Home and Self-Testing

Figure 14. Others

Figure 15. Global Infectious Disease POC Diagnostic Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Infectious Disease POC Diagnostic Market Size (2020-2031) & (US$ Million)

Figure 17. Global Infectious Disease POC Diagnostic Sales (2020-2031) & (K Units)

Figure 18. Global Infectious Disease POC Diagnostic Average Price (US$/Unit) & (2020-2031)

Figure 19. Infectious Disease POC Diagnostic Report Years Considered

Figure 20. Infectious Disease POC Diagnostic Sales Share by Manufacturers in 2024

Figure 21. Global Infectious Disease POC Diagnostic Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Infectious Disease POC Diagnostic Players: Market Share by Revenue in Infectious Disease POC Diagnostic in 2024

Figure 23. Infectious Disease POC Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Infectious Disease POC Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2031)

Figure 26. North America Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2031)

Figure 30. Europe Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2031)

Figure 31. Germany Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Infectious Disease POC Diagnostic Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Infectious Disease POC Diagnostic Revenue Market Share by Region (2020-2031)

Figure 38. China Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2031)

Figure 49. Latin America Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Infectious Disease POC Diagnostic Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Infectious Disease POC Diagnostic Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Infectious Disease POC Diagnostic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Infectious Disease POC Diagnostic by Type (2020-2031)

Figure 59. Global Revenue Market Share of Infectious Disease POC Diagnostic by Type (2020-2031)

Figure 60. Global Infectious Disease POC Diagnostic Price (US$/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Infectious Disease POC Diagnostic by Application (2020-2031)

Figure 62. Global Revenue Market Share of Infectious Disease POC Diagnostic by Application (2020-2031)

Figure 63. Global Infectious Disease POC Diagnostic Price (US$/Unit) by Application (2020-2031)

Figure 64. Infectious Disease POC Diagnostic Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions